# Catalyst Health Ventures

> Catalyst Health Ventures is a VC fund backing Health Care and Medical Device. See 36 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Braintree, United States
- Total investments: 36
- Last investment: Mar 2022
- Lead investor: 56%
- Fund size: $61M
- Last fund: Oct 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/catalyst-health-ventures?trk=company_logo
- Website: https://chv.vc

Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.

## Contacts

5 contacts available for Catalyst Health Ventures. Shizune tracks 5 team members at Catalyst Health Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/catalyst-health-technology-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.4M–$19M |
| Series B | $2.3M–$26M |
| Series C | $1.3M–$40M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 12 | 33% |
| Medical Device | 12 | 33% |
| Medical | 8 | 22% |
| Biotechnology | 8 | 22% |
| Wellness | 2 | 6% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 11 | 31% |
| Series B | 11 | 31% |
| Series C | 3 | 8% |
| Seed | 2 | 6% |
| Funding Round | 2 | 6% |

8 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Darshana Zaveri | Managing Partner | 23 | https://shizune.co/investors/profile/darshana-zaveri |
| David Mackey | Chief Financial Officer | 0 | https://shizune.co/investors/profile/dave-mackey |
| Dianne Letzelter | Senior Vice President of Finance & Investor Relations | 0 | https://shizune.co/investors/profile/dianne-letzelter |
| Joshua Phillips | Managing Partner | 0 | https://shizune.co/investors/profile/joshua-phillips-5f7e |
| Joshua S. Phillips | Managing Partner | 7 | https://shizune.co/investors/profile/joshua-s-phillips |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Avive Solutions | Avive Solutions develops a next-generation Automated External Defibrillator (AED) and software solutions. Avive's AED enables anyone to positively impact the outcome of a Sudden Cardiac Arrest (SCA) rescue by building a more robust solution that addresses the problem of SCA in its entirety. The AED will remove barriers to respond to a SCAscenario. It will be easy to purchase, easy to access in an emergency, easy to keep maintained, and most importantly easy to use effectively when it matters most.Avive Solutions is headquartered in San Francisco, California. | $22M | Series A | Mar 16, 2022 |  |
| Epitel | Epitel is a digital health company developing a wearable, wireless EEG monitoring platform to provide accessible, affordable, and reliable for seizure detection. | $12.5M | Series A | Feb 16, 2022 |  |
| PanTher Therapeutics | PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatmentat the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer. | $5.4M | Series A | May 19, 2021 |  |
| Instylla | Instylla’s focus is to leverage hydrogel technology . | $25.4M | Series B | Oct 14, 2020 |  |
| AtaCor Medical | AtaCor Medical Inc., is a San Clemente-based medical device maker. It designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most. | $25M | Series B | Apr 28, 2020 |  |
| Aria CV | Aria CV was founded in 2010 by Drs. John Scandurra and Karl Vollmers, formerly Fellows at the University of Minnesota’s Medical Devices Center. Aria has an exclusive license to certain patents from the University of Minnesota. Aria CV’s device has the potential to improve outcomes by reducing the workload on the right side of the heart. | $31M | Series B | Feb 25, 2020 |  |
| Conformal Medical | Conformal Medical is an early stage medical device company developing devices to prevent stroke in patients with non-valvular atrial fibrillation. The company's proprietary technology will help left atrial appendage closure to meet its true potential. It was founded in 2016 and is headquartered in Nashua, New Hampshire. | $9M | Series B | Dec 03, 2018 |  |
| Lantos Technologies | Lantos Technologies is the only FDA-cleared 3D ear scanning system that enables custom, in-ear products with superior comfort, sound quality, and performance. Our technology enables the efficient and effective delivery of customized hearing aids and other hearing-related products. | $10M |  | Mar 21, 2018 |  |
| Saphena Medical | Saphena Medical is a medical device company that specializes in cardiovascular space. It offers Venapax, an all-in-one system that provides dissection and simultaneous branch ligation. It delivers a minimal-touch experience with a focus on specimen quality. | $1.3M | Series C | Sep 01, 2017 |  |
| Cruzar Medsystems | Cruzar Medsystems Inc. operates in the healthcare industry manufacturing medical device designed to access peripheral vasculature. The company was incorporated in 2013 and is based in Braintree, Massachusetts. | $2.3M | Series B | Jun 01, 2017 |  |

10 of 36 investments shown.

## Co-investors
- [Catalyst Health Ventures](https://shizune.co/investors/profile/catalyst-health-ventures) — VC Fund, 36 deals together
- [Portfolia](https://shizune.co/investors/profile/portfolia) — VC Fund, 4 deals together
- [Sparta Group](https://shizune.co/investors/profile/sparta-group-llc) — VC Fund, 4 deals together
- [Ascension Ventures](https://shizune.co/investors/profile/ascension-ventures) — VC Fund, 3 deals together
- [Domain Associates](https://shizune.co/investors/profile/domain-associates) — VC Fund, 3 deals together
- [Excelestar Ventures](https://shizune.co/investors/profile/excelestar-ventures) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Medical Device Investors](https://shizune.co/investors/medical-device-investors)
- [Medical Device VC Funds](https://shizune.co/investors/medical-device-vc-funds)
- [Medical Device Investors in United States](https://shizune.co/investors/medical-device-investors-united-states)
- [Medical Device VC Funds in United States](https://shizune.co/investors/medical-device-vc-funds-united-states)

## FAQ

### What does Catalyst Health Ventures invest in?

Catalyst Health Ventures invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 36 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Catalyst Health Ventures's check size?

Catalyst Health Ventures typically joins rounds of $1.4M–$19M at Series A, $2.3M–$26M at Series B and $1.3M–$40M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Catalyst Health Ventures participates in.

### How do I contact Catalyst Health Ventures?

Public channels for Catalyst Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Catalyst Health Ventures?

The team at Catalyst Health Ventures includes Darshana Zaveri (Managing Partner), David Mackey (Chief Financial Officer) and Dianne Letzelter (Senior Vice President of Finance & Investor Relations). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co